相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Frederik Dalgaard et al.
CIRCULATION (2020)
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease
Matthew R. Weir et al.
AMERICAN HEART JOURNAL (2020)
Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial
Yutao Guo et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
Larisa Anghel et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
Guowei Li et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in real-world clinical practice
Xiaoyan Li et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making
Gregory Y. H. Lip et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage Among Individuals With Associated Diagnosis of Atrial Fibrillation
Jonathan L. Thigpen et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage Among Individuals With Associated Diagnosis of Atrial Fibrillation
Jonathan L. Thigpen et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An automated database case definition for serious bleeding related to oral anticoagulant use
Andrew Cunningham et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
分享论文
